Moderna stock skyrocketed 126% in November after news about its coronavirus vaccine candidate. Through December, the Moderna stock has surged 680% through, compared to the broader market's 16.5% return over this period.
Image: David L. Ryan/The Boston Globe via Getty Images
Check out our Festive offers upto Rs.1000/- off website prices on subscriptions + Gift card worth Rs 500/- from Eatbetterco.com. Click here to know more.
Get the latest stories, videos, and podcasts from Forbes India directly in your inbox every Saturday
Post Your Comment
Thank you for your comment, we value your opinion and the time you took to write to us!